Tesla's Trade Split: CEO Buys Billions While Funds Sell, GLJ Warns of 90% Downside

The market is buzzing on robotaxi hype, but a stark warning is being ignored. GLJ Research maintains the Street's lowest price target at $19.05, a level implying over 90% downside from recent prices. That's an extreme bearish call, a full-scale sell signal. Yet, the real signal isn't in the headlines-it's in who is actually putting their money on the line.

On one side, you have the smart money's skin in the game. Tesla CEO Elon Musk has made a powerful statement with his wallet. He has not sold any Tesla shares in the past three years, and his filings show he bought over 2.57 million shares in 2025-a move worth nearly a billion dollars. This isn't just a quiet holding; it's a concentrated, multi-year accumulation that suggests deep conviction from the company's most influential insider.

On the other side, the institutional herd is pulling back. While Musk buys, the broader fund world is selling. A review of 13F filings shows a 9.31% quarterly decline in institutional long-only holdings. The total number of shares held by these funds has dropped sharply, indicating a flight of capital from the stock.

This creates the central question of true conviction. GLJ's extreme bearishness is a clear sell signal, but it stands in direct contrast to the behavior of the man who runs the company and the massive funds that still own a significant stake. When the CEO is buying billions and the stock is down, yet the broader institutional ownership is shrinking, the picture is one of deep division. The smart money's real signal isn't in the price target; it's in the conflicting actions of those with the most to lose.

The GLJ Bear Case: Delivery Mix, Pricing, and Credits

GLJ Research's continued Sell rating, even after lifting its price target to $25.28, points to concrete operational pressures that challenge Tesla's earnings framework. The firm cites three specific headwinds: a weak Q4 delivery mix, ongoing pricing pressure, and the erosion of zero emission credit (ZEC) revenue. This isn't a vague bearish sentiment; it's a focused critique of the company's core auto business fundamentals.

The most immediate pressure is on the top line. Tesla's revenue declined 2.9% year-over-year, a clear sign that the company is struggling to offset falling vehicle deliveries. This revenue drop directly fuels a massive capital demand, with GLJ estimating a need for $30B-$70B in 2026. That's the capital required to fund the company's moonshot pivot to robotics and AI, a massive outlay that strains the balance sheet and raises questions about the sustainability of the current business model.

The robotaxi timeline, a key pillar of the bullish thesis, is now a major vulnerability. Elon Musk has scaled back his ambitions, shifting from a national rollout to a plan for just eight to 10 U.S. metro areas. Yet even this modest goal is stalling. Reports indicate Tesla has not completed the necessary paperwork to launch in targeted states like Arizona and Nevada. In California, the service remains a supervised test with a human driver, not a true autonomous offering. This regulatory lag is a stark contrast to the CEO's public statements that the robotaxi is "critical" to Tesla's future. It suggests the operational execution is far behind the hype, creating a tangible risk to the long-term valuation story.

The bottom line is that GLJ sees a company under pressure on multiple fronts. Weak sales and pricing are squeezing margins, while the capital-intensive robotaxi dream is facing real-world regulatory hurdles. For the smart money, this creates a clear divergence: the institutional herd is selling, the CEO is buying, but the earnings narrative is being challenged by these operational facts.

Valuation and the Path to Catalysts

The investment case for Tesla is now a high-stakes gamble, with the stock's valuation hanging by a thread on a handful of 2026 milestones. The market is split in two, with price targets ranging from a pessimistic $119 to an optimistic $600. That fivefold gap isn't just a difference of opinion-it's a direct reflection of the polarized view on the company's future. One side sees a carmaker with declining sales and a capital-hungry pivot. The other sees an AI platform, with a valuation premium of roughly $750 billion, built on the promise of robotaxis and autonomous data. The real story, however, is in the gap between those promises and the regulatory reality.

The key catalysts for the bullish thesis are all set for 2026. CEO Elon Musk has publicly stated the company is gearing up to start production of three new products this year: the Tesla Semi, the Optimus robot, and its dedicated robotaxi, the Cybercab. The Cybercab is the linchpin, with plans to begin mass production in April. Yet, the path to commercial operation is blocked by a critical regulatory gap. Despite Musk's public statements about an imminent launch, Tesla has not taken the necessary steps to secure driverless vehicle permits in California. State records reveal the company logged zero autonomous test miles for the sixth consecutive year, a key requirement for approval. Competitors like Waymo have logged millions of miles; Tesla's inaction is stark.

This delay creates a tangible risk to the bullish thesis. The robotaxi business model, which some analysts believe could drive 88% of Tesla's enterprise value by 2029, requires regulatory clearance to operate without safety drivers. Without it, the entire revenue loop-converting vehicles into a ride-hailing fleet via unsupervised FSD-cannot begin. The company's own plans for Cybercab production in 2026 are thus disconnected from the legal framework needed to deploy them. This regulatory lag is a major vulnerability that the market's high valuation must ignore.

The bottom line is that the 2026 milestones are facing significant delays. The company must not only produce the Cybercab but also complete the testing and permit applications to operate it commercially. Until that happens, the AI/robotics narrative remains a story, not a financial reality. For the smart money, the extreme valuation polarized between $119 and $600 is a warning sign. It means the market is pricing in a successful, timely execution of these very delays. When the operational timeline is so far behind the hype, the risk of a painful recalibration is high.